Compound: Nilotinib

Drug Target: ABL

Drug Target pathway: ABL signaling

DatasetDatasets
GDSC1: Screened in 96 or 384-well plates with Cyto60 or Resazurin endpoint
GDSC2 (recommended where available): 1536-well plates with CellTiterGlo endpoint
See documentation for more information and screening differences



Tissue specific analysis

Nilotinib IC50 values for BCR.ABL_mut

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.